Assembly Biosciences, Inc.
ASMB
$26.74
$2.4810.22%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 8.21M | 42.47M | 10.79M | 9.63M | 9.42M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.21M | 42.47M | 10.79M | 9.63M | 9.42M |
| Cost of Revenue | 14.90M | 17.25M | 16.59M | 16.13M | 14.85M |
| Gross Profit | -6.69M | 25.22M | -5.80M | -6.50M | -5.43M |
| SG&A Expenses | 4.68M | 5.42M | 5.09M | 4.59M | 4.51M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.58M | 22.67M | 21.67M | 20.72M | 19.36M |
| Operating Income | -11.37M | 19.80M | -10.88M | -11.09M | -9.94M |
| Income Before Tax | -9.08M | 22.09M | -9.20M | -10.20M | -8.82M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9.08M | 22.09M | -9.20M | -10.20M | -8.82M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.08M | 22.09M | -9.20M | -10.20M | -8.82M |
| EBIT | -11.37M | 19.80M | -10.88M | -11.09M | -9.94M |
| EBITDA | -11.34M | 19.83M | -10.85M | -11.06M | -9.91M |
| EPS Basic | -0.54 | 1.30 | -0.72 | -1.33 | -1.17 |
| Normalized Basic EPS | -0.34 | 0.82 | -0.45 | -0.83 | -0.73 |
| EPS Diluted | -0.54 | 1.30 | -0.72 | -1.33 | -1.17 |
| Normalized Diluted EPS | -0.34 | 0.82 | -0.45 | -0.83 | -0.73 |
| Average Basic Shares Outstanding | 16.90M | 16.94M | 12.69M | 7.66M | 7.51M |
| Average Diluted Shares Outstanding | 16.90M | 16.94M | 12.69M | 7.66M | 7.51M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |